[…] at www.safalab.com The US government in a reactive and careless manner is outlawing the safe incandescent light bulbs and pushing dangerous (albeit energy […]
Going Green and saving the world? Watch out for CF Bulbs… Read More »
[…] and efficacy in the neoadjuvant chemohormonal treatment of breast cancer. Dr. Love is the chief medical spokesperson for the Breast Cancer Coalition. October 1991: […]
IPT for Cancer – recent developments Read More »
[…] hence became the first major American medical body to state : “It is essential that any new standards for cell phones or other wireless […]
Electrical Pollution in the home. Read More »
[…] and efficacy in the neoadjuvant chemohormonal treatment of breast cancer. Dr. Love is the chief medical spokesperson for the Breast Cancer Coalition. October 1991: […]
IPT Here’s the science! Read More »
[…] years. I have gradually come to the conclusion that the cholesterol hypothesis is a very poor one. Perhaps it can be saved by discussing […]
Dr. Hoffer on Cholesterol and Niacin Read More »
[…] or nuclear power plant disasters. Potassium iodide (usually taken in tablet form) is recommended by “public health” authorities to protect the thyroid gland against […]
Iodine – read all about it! Read More »
[…] told that the definition of a medical disaster, according to Big Pharma, is anything which creates or eliminates the need for vast amounts of […]
The Economist on pros and cons and costs of chemotherapy Read More »
Dr. Weeks’ Comment: My heart is sad at today’s news of a young, elite college athlete dying of an “unexpected” heart attack during […]
Adrenochrome and your Heart Read More »
[…] to avoid litigation, often assert that because the energy of the fields is too low to give significant heating, they cannot have any biological […]
The Biological Effects of Weak Electromagnetic Fields Read More »
[…] Weeks’ Comment: In chemotherapy, as in life in general, buyer beware. Here is an insightful article reflecting on the historical view of chemotherapy’s effectiveness […]
What The Economist thinks about chemotherapy. Read More »